Filter Results:
(132)
Show Results For
- All HBS Web
(579)
- People (4)
- News (132)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
Show Results For
- All HBS Web
(579)
- People (4)
- News (132)
- Research (350)
- Events (2)
- Multimedia (4)
- Faculty Publications (168)
Sort by
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
graduation from Harvard Business School and which successfully developed and commercialized a market-leading drug to treat cardiovascular disease. But in addition to drawing on technical degrees and... View Details
Keywords: Deborah Blagg
- 01 Sep 2004
- News
American Dream
visitors in their tracks. “I wonder if I should turn him down a little,” Hustead muses. As president of Wall Drug in Wall, South Dakota, Hustead ponders this and many other details of a 76,000-square-foot roadside attraction, not far from... View Details
- 01 Jun 2016
- News
@Soldiers Field
diverse, outstanding future leaders and who will go on to make a real difference in the world.” Baker Library’s Historical Collections acquired a trove of archival materials from Genzyme, one of the world’s leading biotechnology firms. A pioneer in the View Details
- 07 Oct 2014
- News
Network Effect
was shocked by their advice. “They said, ‘Try three Advil a day. It might help. There are a few FDA-approved drugs for Alzheimer’s disease, and they won’t help,’” he recalls. McCance, a venture- capital pioneer with Greylock Partners, had... View Details
Keywords: Linda Kush
- 01 Sep 2008
- News
In Africa, Porter Sees Lessons for Health Care
delivery systems of both developing and advanced countries: fragmentation, inefficiency, and organization around discrete interventions (such as delivering drugs or screening) rather than integrated care.... View Details
- 01 Mar 2011
- News
Wyss Celebrated for Career, Conservation
Hansjörg Wyss (MBA 1965) has been unusually public of late, celebrated for his visionary accomplishments in health care and conservation. Wyss, 75, founded Synthes USA, a Swiss-American firm, in 1974 and led it to global prominence as a pioneer in the View Details
- 15 Dec 2024
- News
After Ozempic
on drug development and climate research. With investments at this scale, the foundation is positioned to do more than merely contributing to progress; it’s setting the stage for transformative changes that... View Details
- 01 Sep 2011
- News
Alumni Team Up to Fight Cancer
networking among its alumni community. Bowes, founding partner of US Venture Partners, and Giusti, founder of the Multiple Myeloma Research Foundation (MMRF), discussed the need for innovative, results-oriented biomedical research and View Details
- 25 Apr 2014
- News
A revolution in healing
Stéphane Bancel (MBA 2000) is president and CEO of Moderna Therapeutics, which is producing a new drug application that could revolutionize the biotech world. It hinges on messenger RNA, or mRNA, the molecules responsible for transporting... View Details
- 01 Sep 2017
- News
Ink: Miami’s Dark Neon Era, the Language of Success, and Getting Psyched Up
and two other amazing, true stories NEW Hotel Scarface by Roben Farzad “There’s so much unresolved about Miami’s cocaine coming-of-age. I found the address where the Cold War crashed into the war on drugs crashed into the cocaine wars... View Details
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
The blind man depicted in the sculpture suffers from river blindness, a disease that ravaged countless lives in the developing world until Merck researchers discovered the breakthrough drug Mectizan. The... View Details
- 01 Dec 2018
- News
Case Study: Your Data, Your Health
potential fertility with her ob-gyn, Tariyal was told that she could come back for a clinical workup after she had tried and failed to conceive for a year. Determined to give women more agency over their health, Tariyal cofounded NextGen Jane in 2014 with patented... View Details
Keywords: Jen McFarland Flint
- 01 Mar 2010
- News
Noted & Quoted
“Unfortunately, the technology for growing flu viruses to make vaccines is fifty years old — it’s chicken eggs.” — HBS Professor of Management Practice and former Merck CEO Raymond Gilmartin, at a November HBS panel discussion on drug... View Details
- 01 Jun 2000
- News
The Business of Biotech
"blockbusters" will disappear. Recent developments suggest that doctors will eventually be able to treat patients more effectively with medicine tailored to their genetic makeup, including, in some cases, gene replacement therapies. "The... View Details
Keywords: Julia Hanna
- 01 Jan 2009
- News
Kathryn E. Giusti, MBA 1985
aided in the development of drugs for this and other cancers. A successful marketing executive who had worked at Merck, Gillette, and Searle, Giusti was diagnosed with myeloma in 1996. As she faced a grim... View Details
- 01 Jan 2003
- News
Daniel L. Vasella, M.D.
quickly," he observes. Under his guidance, Novartis has been a leader not only in developing new drugs but in making them accessible to those in need around the globe. Dan Vasella has experienced first-hand... View Details
- 04 Sep 2019
- News
Deep Dive
manage a worldwide team to develop a virtual product—diving to the bottom of all five oceans, and doing a lot of science along the way.” The Five Deeps Expedition, Vescovo said, has “proven to be as challenging as any business thing I’ve... View Details
- 01 Jun 1997
- News
Thomas C. Høegh
child-focused development organization. The Expedition for Education has secured backing for Childreach's school-support efforts from regional companies and HBS alumni. In return, Høegh and other "cyberexperts" on the HBS team will... View Details
Keywords: Garry Emmons
- 25 Aug 2014
- News
Wendell P. Weeks, MBA 1987
brink of failure through a painful restructuring and commitment to both innovation and the diversification of its product lines. “We make products that change the world,” he says, noting Corning’s development of LCD glass; tools to... View Details
Keywords: Susan Young
- 01 Jun 2018
- News
The Long Run
trajectory of overdose deaths from prescription drugs and heroin. According to the Centers for Disease Control and Prevention, the US death rate from opioid overdose has increased over 400 percent since 1999; the picture is even grimmer... View Details